Satoshi Hara

Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor

Hiroaki Akamatsu, Yukihiro Toi, Hidetoshi Hayashi et al. · JAMA Oncology · 2021 · 178 citations · Full text

New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases

Kazunori Yamada, Motohisa Yamamoto, Takako Saeki et al. · Arthritis Research & Therapy · 2017 · 145 citations · Full text

Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study

Daichi Fujimoto, Hiroshige Yoshioka, Yuki Kataoka et al. · Lung Cancer · 2018 · 142 citations

Medicine, Clinical Trials, Immune Checkpoint Inhibitor +6

Pseudoprogression in Previously Treated Patients with Non–Small Cell Lung Cancer Who Received Nivolumab Monotherapy

Daichi Fujimoto, Hiroshige Yoshioka, Yuki Kataoka et al. · Journal of Thoracic Oncology · 2018 · 116 citations

Medicine, Cancer Management, Nivolumab Monotherapy +6

State of charge estimation for lithium-ion batteries: An adaptive approach

Huazhen Fang, Yebin Wang, Zafer Şahinoğlu et al. · Control Engineering Practice · 2014 · 88 citations

State Estimation, Adaptive Filter, Electrical Engineering +7